Health Canada Summary Basis of Decision Tuesday, November 26, 2013. Istodax, romidepsin, 10 mg/vial, intravenous infusion, Celgene Inc. Submission Control Number 152293.
Health Canada Post-Authorization Activity Table, 2013/11/07. Stribild, 150 mg elvitegravir, 150 mg cobicistat, 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate, tablet, Gilead Sciences Canada Inc.
New PDF fillable form now available for Submission Certification: NDSs, SNDSs, NCs.
New PDF fillable form now available for Qualified Investigator Undertaking.
Harper Government launches Clinical Trials Database – New initiatives provide guidance and education on clinical trials for Canadians
The Honourable Leona Aglukkaq, Minister of Health, today announced the launch of the Government of Canada’s new public database of Health Canada-authorized drug clinical trials involving patients, as well as the completion of a joint project to develop new standards for research ethics boards that oversee clinical trials.
Health Canada Launches Consultation Process to Improve Labelling and Classification of Workplace Chemicals
Today, the Honourable Leona Aglukkaq, Minister of Health, announced that Health Canada is launching a consultation that begins the process of applying the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for workplace chemicals in Canada.
New PDF fillable form now available for Drug Identification Number (DIN) Submission Certification
Health Canada Post-Authorization Activity Table, 2013/11/07. Adcetris, 50 mg brentuximab vedotin, lyophilized powder for solution, Seattle Genetics, Inc.